Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ogawa A et al. – The data from this study indicate the importance of the mTOR pathway in the development of pulmonary vascular remodeling in CTEPH and suggests a potential therapeutic benefit of rapamycin (or inhibition of mTOR) in these patients.

Related Articles

Sarcoidosis-Associated Fibrosing Mediastinitis with Resultant Pulmonary Hypertension: A Case Report and Review of the Literature
Respiration, 10/06/09    Relevance Score: 70%

Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension
American Journal of Respiratory and Critical Care Medicine, 10/27/09    Relevance Score: 69%

New finding could lead to cure of pulmonary arterial hypertension
Internet Source, 10/26/09    Relevance Score: 69%

Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease
British Journal of Haematology, 10/05/09    Relevance Score: 69%

The Use of Sildenafil in Persistent Pulmonary Hypertension of the Newborn
American Journal of Perinatology, 10/28/09    Relevance Score: 68%

Today in CV/Thromboembolic...keeping you current

Carotid body and cardiorespiratory alterations in intermittent hypoxia: the oxidative link
European Respiratory Journal , 12/15/09

Abnormal troponin I levels in acute pulmonary embolism without abnormal concentrations of D-dimer at admission
International Journal of Cardiology, 12/14/09

Oral contraceptives and venous thromboembolism: identifying the safest option
Expert Review of Cardiovascular Therapy , 12/14/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address